A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Clinical trial NCT07137494 · RECRUITING

Trial details

NCT number: NCT07137494
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Central Nervous System (CNS) Lymphoma Secondary Central Nervous System Lymphoma

Start date: 2025-08-14
Primary completion: 2028-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.